Consumers' valuation of primary care-based treatment options for mental and substance use disorders

Andrew J. Epstein, Colleen L. Barry, David A. Fiellin, Susan H. Busch

Research output: Contribution to journalArticlepeer-review

Abstract

Most individuals with substance use disorders and with mental disorders do not receive treatment. If treatment options were more attractive, treatment rates might increase. The advantages of novel approaches, including primary care- based treatment and collaborative care in a primary care setting, have been documented.However, less is known about consumers' valuation of these options. The authors assessed monetary valuation of these treatment types compared with usual care in a specialty treatment setting. Contingent valuation methods were used in a Web-based randomized vignette experiment that involved 2,146 individuals who screened positive for a drug or alcohol use disorder or a mental disorder. Participants valued a primary care-based treatment visit over usual care in a specialty treatment setting by $9.00 and a collaborative care visit over usual care in a specialty treatment setting by $5.85.

Original languageEnglish (US)
Pages (from-to)772-774
Number of pages3
JournalPsychiatric Services
Volume66
Issue number8
DOIs
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Consumers' valuation of primary care-based treatment options for mental and substance use disorders'. Together they form a unique fingerprint.

Cite this